CANDI ERVEN: Open Payments
NPI 1780752592 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 14 payments from 7 companies in 2025. Trend: 2023 $370 · 2024 $400 · 2025 $600
Food & beverage: $366Consulting: $150Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $239 |
| Biogen, Inc. | 1 | $150 |
| Madrigal Pharmaceuticals | 2 | $102 |
| ABBVIE INC. | 3 | $54 |
| CSL Behring | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: TREMFYA, TYSABRI, REZDIFFRA, MAVYRET, Kcentra, ENTYVIO, VOQUEZNA.
Industry payments across MO — which companies pay providers there.
